Dr. Reddy's Laboratories ... (RDY)
NYSE: RDY
· Real-Time Price · USD
14.21
0.10 (0.71%)
At close: Aug 15, 2025, 12:23 PM
Dr. Reddy's Laboratories Income Statement
Financials in INR. Fiscal
year is
April - March.
Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 334.26B | 325.54B | 311.31B | 299.87B | 288.51B | 279.16B | 271.3B | 266.86B | 261.11B | 245.88B | 237.28B | 222.78B | 217.35B | 214.39B | 207.31B | 203.41B | 194.74B | 189.72B | 186.76B | 181.3B | 180.34B |
Cost of Revenue | 141.55B | 135.11B | 126.66B | 122.07B | 118.11B | 115.56B | 97.52B | 95.19B | 92.56B | 90.88B | 105.19B | 102.17B | 103.2B | 100.55B | 96.83B | 95.01B | 90.72B | 86.64B | 86.25B | 83.6B | 81.44B |
Gross Profit | 192.71B | 190.43B | 184.65B | 177.8B | 170.4B | 163.61B | 173.78B | 171.67B | 168.55B | 155B | 132.09B | 120.61B | 114.15B | 113.84B | 110.47B | 108.4B | 104.02B | 103.08B | 100.51B | 97.69B | 98.91B |
Operating Income | 71.39B | 71.84B | 68.98B | 67.53B | 67.84B | 67.56B | 74.72B | 73.88B | 72.14B | 66.72B | 52.12B | 44.93B | 40.92B | 35.31B | 35.53B | 28.5B | 24.69B | 26.19B | 25.22B | 17.15B | 16.16B |
Interest Income | 3.06B | 1.93B | 2.02B | 1.9B | 1.95B | 2.28B | 2.1B | 1.79B | 1.29B | 1.18B | 1.88B | 1.87B | 1.89B | 1.88B | 874M | 869M | 754M | 826M | 841M | 791M | 944M |
Pretax Income | 77.01B | 76.78B | 72.75B | 72.26B | 72.23B | 71.87B | 69.14B | 67.23B | 64.21B | 60.4B | 49.59B | 42.96B | 39.53B | 32.3B | 37.89B | 31.02B | 26.96B | 28.32B | 27.39B | 19.28B | 18.32B |
Net Income | 56.8B | 56.54B | 53.68B | 53.33B | 55.58B | 55.68B | 52.21B | 50.89B | 47.22B | 45.07B | 36.35B | 30.94B | 29.74B | 23.57B | 28.23B | 21.36B | 19.06B | 19.15B | 21.26B | 15.36B | 18.66B |
Selling & General & Admin | 94.36B | 93.87B | 90.29B | 86.4B | 82.19B | 77.2B | 85.02B | 82.77B | 80.53B | 78.33B | 65.71B | 63.14B | 62.53B | 62.08B | 60.69B | 59.66B | 56.82B | 54.56B | 52.46B | 50.74B | 54.41B |
Research & Development | 27.43B | 27.38B | 27B | 25.91B | 24.08B | 22.87B | 21.36B | 20.62B | 20.04B | 19.38B | 18.34B | 17.68B | 17.27B | 17.48B | 17.25B | 17.2B | 17.09B | 16.54B | 16.64B | 16.48B | 15.78B |
Other Expenses | -473M | -2.67B | -968M | -525M | -465M | n/a | -2.39B | -1.59B | -2.02B | -8.02B | -5.92B | -6.93B | -7.12B | -1.58B | -1.88B | -1.81B | -1.36B | -1.02B | -675M | -707M | -665M |
Operating Expenses | 121.32B | 118.58B | 115.46B | 110.42B | 103.09B | 96.58B | 101.35B | 99.66B | 97.78B | 89.69B | 78.13B | 73.89B | 72.68B | 77.99B | 76.06B | 75.08B | 72.59B | 70.12B | 68.53B | 66.55B | 69.56B |
Interest Expense | 3.06B | 2.23B | 2.17B | 1.74B | 1.34B | 1.71B | 1.47B | 1.5B | 1.45B | 1.43B | 1.39B | 1.19B | 1.11B | 958M | 939M | 912M | 930M | 970M | 903M | 867M | 919M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 15.53B | 15.53B | 15.53B | 15.53B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 262.87B | 253.69B | 242.12B | 232.49B | 221.2B | 212.13B | 198.87B | 194.84B | 190.34B | 180.57B | 183.32B | 176.05B | 175.88B | 178.54B | 172.9B | 170.08B | 163.31B | 156.76B | 154.78B | 150.16B | 150.99B |
Income Tax Expense | 19.59B | 19.54B | 18.3B | 18.07B | 16.65B | 16.19B | 16.93B | 16.34B | 16.99B | 15.33B | 13.24B | 12.01B | 9.79B | 8.73B | 9.66B | 9.66B | 7.9B | 9.18B | 6.14B | 3.92B | -342M |
Shares Outstanding (Basic) | 832.04M | 833.31M | 833.31M | 833.62M | 833.93M | 832.57M | 832.57M | 831.83M | 830.86M | 830.68M | 830.4M | 825.52M | 829.79M | 829.79M | 829.61M | 829.43M | 828.69M | 829.09M | 831.93M | 829.31M | 828.99M |
Shares Outstanding (Diluted) | 833.02M | 834.3M | 834.3M | 834.11M | 833.93M | 833.95M | 833.88M | 833.52M | 832.78M | 832.26M | 831.81M | 831.81M | 831.65M | 831.75M | 831.57M | 831.52M | 831.1M | 831.33M | 831.93M | 831.66M | 830.9M |
EPS (Basic) | 68.19 | 67.84 | 64.41 | 64.01 | 66.74 | 66.93 | 62.78 | 61.24 | 56.93 | 54.36 | 43.86 | 37.36 | 35.84 | 28.42 | 34.05 | 25.77 | 23.00 | 23.10 | 25.64 | 18.53 | 22.53 |
EPS (Diluted) | 68.11 | 67.78 | 64.35 | 63.95 | 66.66 | 66.81 | 62.67 | 61.12 | 56.74 | 54.18 | 43.70 | 37.21 | 35.76 | 28.35 | 33.96 | 25.70 | 22.94 | 23.04 | 25.58 | 18.47 | 22.46 |
EBITDA | 98.08B | 95.2B | 88.43B | 85.77B | 82.16B | 81.63B | 79.93B | 77.14B | 76.22B | 64.59B | 59.79B | 53.24B | 47.85B | 47.73B | 45.36B | 44.49B | 42.9B | 44.66B | 45.37B | 31.93B | 33.75B |
EBIT | 80.07B | 78.11B | 74.01B | 73.1B | 72.66B | 72.39B | 69.39B | 67.51B | 64.44B | 61.8B | 57.22B | 50.38B | 46.88B | 39.49B | 36.91B | 30.02B | 25.98B | 27.38B | 28.3B | 20.14B | 19.24B |
Depreciation & Amortization | 18.01B | 17.06B | 16.22B | 15.27B | 15.08B | 14.84B | 14.32B | 13.82B | 13.15B | 12.64B | 12.4B | 12.11B | 11.97B | 11.82B | 12.04B | 12.28B | 12.56B | 12.8B | 12.59B | 12.46B | 12.53B |